The potential for sophisticated diagnostic results in even the smallest or most remote laboratories continues to expand. That expansion includes the possibility that, with proper training, even single-pathologist facilities can produce their own molecular results. The advance of the so-called “commoditization of next-generation sequencing”, a concept going back at least a decade, helps bring a level of clinical service, public health insights, and individual lab reporting power that can truly transform health outcomes for a broad range of people. Medsoft Partners exists for just such labs: under-resourced, isolated, over-burdened. These are facilities in various parts of the world often hampered by high patient-to-provider ratios and sub-standard means for serving those patients. The opportunity exists now to give these labs the basics and ready them for their molecular futures. Medical technology for all.